Tuesday, December 1, 2015   

Novartis bosses in Japan shown the door
(04-03 14:03)

Swiss pharmaceutical giant Novartis said it was replacing the top executives at its Japanese unit over allegations the division hid serious potential side effects of leukaemia treatments from regulators.
David Epstein, the head of the firm's pharmaceutical division, told a news briefing in Tokyo that the senior managers “resigned, they are out of the company,’’ adding that “this kind of behavior is unacceptable and a clear violation of our code of conduct''.
Other Business breaking news:
Coca-Cola funded controversial anti-obesity group winds up (12-01 14:14)
Amazon says drones will deliver 5 pound packages (12-01 14:10)
Australia keeps rates at 2pc (12-01 14:07)
Samsung shoves aside mobile unit boss Shin Jong Kyun (12-01 14:04)
China factory output hits new low, services improve (12-01 14:00)
India keeps rates unchanged (12-01 13:56)
Macau November gambling revenue shrinks to HK$15.9b (12-01 13:52)
American Airlines cabin crew charged with on board assaults (12-01 13:46)
EU stands firm on Israeli occupied West Bank products labeling (12-01 13:40)
Athens urges quick start to debt relief talks (12-01 13:39)

More breaking news >>

© 2015 The Standard, The Standard Newspapers Publishing Ltd.
Contact Us | About Us | Newsfeeds | Subscriptions | Print Ad. | Online Ad. | Street Pts


Home | Top News | Local | Business | China | ViewPoint | CityTalk | World | Sports | People | Central Station | Spree | Features

The Standard

Trademark and Copyright Notice: Copyright 2015, The Standard Newspaper Publishing Ltd., and its related entities. All rights reserved.  Use in whole or part of this site's content is prohibited.   Use of this Web site assumes acceptance of the
Terms of Use, Privacy Policy Statement and Copyright Policy.  Please also read our Ethics Statement.